TeknoSeed AB

Overview

TeknoSeed AB is a venture capital firm based in Lund, Sweden, specializing in early-stage investments in technology startups with ties to the R&D community in southern Sweden. The firm focuses on sectors such as biotechnology, medical devices, pharmaceuticals, gaming, software, medical equipment, semiconductors, and telecommunications. TeknoSeed seeks to become a partner in the earliest stages of business formation, aiming to bridge the gap between early-stage high-tech ideas and later-stage venture capital. The firm has made over 30 investments since its inception in 1997, with a capital investment range between $300,000 and $3 million, depending on the stage and need. TeknoSeed acts as an active owner, aiming to increase the value of the company and eventually enable a successful exit through a trade sale or an initial public offering on a stock exchange. Through its extensive network, the firm provides qualified support for companies at different phases of development. The business should be research-based and located in the south of Sweden, fulfilling criteria such as a high technological or intellectual level, being a new or relatively recently started company, having high growth potential, and the possibility of reaching an international market. Key people include Adam Schatz, Managing Director, who previously worked at Goldman Sachs in London and Deutsche Morgan Grenfell in Stockholm, and Per Heander, Chairman of the Board & former Investment Manager, who previously worked at Teknopol and SEB Merchant Banking. Notable portfolio companies include Airec, Bone Support, Phase Holographic, and Scalado.

Investment Focus

• Research-based business
• Located in southern Sweden
• High technological or intellectual level
• New or relatively recently started company
• High growth potential
• Potential for international market reach

Portfolio Companies